News & Blog
News & Blog
PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program
Meet the Community 2: A Closer Look — Alijana Shakya
2024 Fuzzy Buzzy Recap
September 2024 – Advocacy Newsletter
Meet the Community 2: A Closer Look – Alex Fielding
Congressional Resolution Passes to Designate September 25 as “National Ataxia Awareness Day”
Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich’s Ataxia
Meet the Community: Allison Rice
Stealth BioTherapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance and FARA Ireland to Develop Investigational Mitochondrial Therapeutic SBT-589 for Friedreich’s Ataxia
Meet the 2024 FARA Fellows
